Duffau Hugues
J Neurosurg. 2025 Apr 18:1-8. doi: 10.3171/2025.1.JNS242462.
In low-grade glioma (LGG), awake surgery (AS) with intraoperative functional mapping minimizes morbidity while increasing the extent of resection (EOR). However, the actual role of AS for insular LGG resection through the opercula is still debated. The aim of this study was to investigate the long-term results after AS via a transcortical approach in patients with LGG within the insula, and to compare outcomes between pure insular gliomas and gliomas also invading other lobes.
Patients who underwent AS with functional-based resection via the opercula performed by the author for an isocitrate dehydrogenase-mutant grade 2 glioma involving the insula were selected (June 2002-January 2024). Functional and oncological outcomes were analyzed by comparing pure insular gliomas (group 1) versus insular-centered gliomas also involving the frontal and/or temporal and/or parietal lobes (group 2).
In this consecutive cohort, 309 ASs were achieved in 253 patients (132 men [52.2%], mean age 37.5 ± 9.5 years). Among 214 patients (84.5%) with epilepsy before surgery, 55 had intractable seizures (21.7%). The preoperative mean Karnofsky Performance Scale score was 93.1 ± 7.4, with 206 patients (81.4%) working before surgery. The series included 147 left-sided gliomas (58.1%), with a mean preoperative tumor volume for both sides of 70.1 ± 50.1 cm3 with 39 total tumors (15.4%) in group 1 and 214 total tumors (84.6%) in group 2. No patients except 2 (99.2%) had a permanent postoperative deficit (mean Karnofsky Performance Scale score 93 ± 6.6), with 199 patients returning to work (96.6%). Only 20 patients (7.9%) continued to suffer from intractable epilepsy. The mean EOR was 89.4% ± 8.4% (mean residual tumor volume: 9.6 ± 13.1 cm3). There were 166 astrocytomas (65.6%) and 87 oligodendrogliomas (34.4%). Fifty-three patients (20.9%) received immediate postoperative adjuvant therapy and 49 patients (19.3%) underwent subsequent AS. The mean follow-up was 7.1 ± 3.9 years, with an overall survival rate of 80.2% (203 patients were still alive at last evaluation). More patients had an incidental glioma in group 1 (p = 0.00009), whereas there was a higher rate of intractable seizures (p = 0.0019) and a greater tumor volume before surgery in group 2 (p < 0.00001). Nonetheless, the EOR and the rate of postoperative intractable seizures were similar in both groups, with more patients in group 2 resuming work (p = 0.001).
This is the largest homogeneous surgical experience of LGGs involving the insula that were resected through the opercula based on awake mapping. The results show a high percentage of functional preservation and return to work, with a high overall survival rate.
在低级别胶质瘤(LGG)中,术中功能定位的清醒手术(AS)可将发病率降至最低,同时提高切除范围(EOR)。然而,AS对于通过脑盖进行岛叶LGG切除的实际作用仍存在争议。本研究的目的是调查经皮质入路对岛叶LGG患者进行AS后的长期结果,并比较纯岛叶胶质瘤与侵犯其他脑叶的胶质瘤之间的预后。
选择作者通过脑盖对异柠檬酸脱氢酶突变的2级岛叶胶质瘤进行基于功能的切除而接受AS的患者(2002年6月至2024年1月)。通过比较纯岛叶胶质瘤(第1组)与以岛叶为中心且累及额叶和/或颞叶和/或顶叶的胶质瘤(第2组),分析功能和肿瘤学结果。
在这个连续队列中,253例患者(132例男性[52.2%],平均年龄37.5±9.5岁)完成了309次AS。在术前有癫痫的214例患者(84.5%)中,55例有难治性癫痫发作(21.7%)。术前平均卡氏功能状态评分93.1±7.4,206例患者(81.4%)术前仍在工作。该系列包括147例左侧胶质瘤(58.1%),两侧术前平均肿瘤体积为70.1±50.1cm³,第1组有39个肿瘤(15.4%),第2组有214个肿瘤(84.6%)。除2例患者(99.2%)外,无患者有永久性术后神经功能缺损(平均卡氏功能状态评分93±6.6),199例患者恢复工作(96.6%)。仅20例患者(7.9%)继续患有难治性癫痫。平均EOR为89.4%±8.4%(平均残余肿瘤体积:9.6±13.1cm³)。有166例星形细胞瘤(65.6%)和87例少突胶质细胞瘤(34.4%)。53例患者(20.9%)接受了术后即刻辅助治疗,49例患者(19.3%)接受了后续AS。平均随访7.1±3.9年,总生存率为80.2%(最后一次评估时有203例患者仍存活)。第1组有更多患者为偶然发现的胶质瘤(p = 0.00009),而第2组难治性癫痫发作率更高(p = 0.0019)且术前肿瘤体积更大(p < 0.00001)。尽管如此,两组的EOR和术后难治性癫痫发作率相似,第2组有更多患者恢复工作(p = 0.001)。
这是通过基于清醒定位的脑盖对累及岛叶的LGG进行切除的最大规模同类手术经验。结果显示功能保留和恢复工作的比例很高,总生存率也很高。